Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MyStem is an Italian biotechnology company specializing in regenerative medicine through the development of point-of-care autologous cell therapy solutions. The company's core technology is the MyStem Kit, a proprietary, closed-system medical device used to extract and concentrate mesenchymal stem cells (MSCs) from a patient's own adipose tissue or bone marrow. This system is primarily utilized in orthopedic surgery, wound care, and aesthetic medicine to promote tissue repair and reduce inflammation. MyStem's products are CE-marked and marketed globally, supported by clinical data demonstrating efficacy in treating conditions such as osteoarthritis and chronic skin ulcers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MyStem.